Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart’s electrical system. Atrial fibrillation (AF) is one of the most commonly occurring cardiac rhythm conditions. Being a potentially life threatening disease and expensive to treat, the overall healthcare system views the treatment for this condition as a strategically critical area to address. This report analyzes the market for atrial fibrillation market from the point of view of various pharmacological and non-pharmacological treatment products used for the treatment of AF.
Albany, NY -- (SBWIRE) -- 04/30/2014 -- Atrial Fibrillation Market was valued at USD 6.1 billion in 2012 and it is expected to reach an estimated value of USD 14.8 billion in 2019, growing at a CAGR of 13.4% from 2013 to 2019.
Browse the full report with Complete TOC at http://www.transparencymarketresearch.com/atrial-fibrillation-market.html
Rising global base of geriatric population inducing an accelerated growth in the incidence rates of atrial fibrillation is one of the highest impact-rendering drivers for this market. In addition, favorable results exhibited by clinical trials promoting combined pharmacological therapy such as the HARMONY trial and rising prevalence of disorders causing atrial fibrillation such as hypertension and obesity will also serve the market as drivers. The future growth of this market will be ensured by the introduction of advanced treatment procedures such as hybrid ablation and the rising prevalence of atrial fibrillation in emerging Asian economies.
On account of the fact that pharmacological treatment procedures are more frequently administered to the patients suffering from atrial fibrillation and are a cheaper alternative to non-pharmacological procedures, pharmacological procedures held the majority of market share in 2012. With the introduction of new drugs such as Bristol Myer Squibb's NTC-801, Merck's Vernakalant, Boehringer Ingelheim's Pradaxa, the market share of pharmacological treatment procedures is expected to further increase by 2019.
The non-pharmacological treatment market was led by the catheter ablation market and its market share was valued at over 45% in 2012. The introduction of new catheter ablation systems such as CardioFocus's HeartLight Endoscopic Ablation System (EAS) laser ablation catheter, Endosense's TactiCath and Biosense Webster's ThermoCool SmartTouch, will help the catheter ablation market to further enhance its market share by 2019.
The radiofrequency based catheter ablation treatment for atrial fibrillation market led the catheter ablation market in terms of market share in 2012 majorly on account of the facts that it has a relatively lower procedural duration and cost and has high success rates associated with it.
High prevalence of atrial fibrillation coupled with the availability of high disposable incomes amongst patients and sophisticated healthcare infrastructure, has led the North American atrial fibrillation market to hold the majority of the market share in 2012. However, this region is expected to lose its market share to relatively faster growing Asia-Pacific region.
Some of the key players of this market include Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Bayer/Johnson & Johnson, Medtronic, Inc., St. Jude Medical, Inc. and AtriCure, Inc.
Related & Recently Published Reports by Transparency Market Research
Transcriptomics Technologies Market: http://www.transparencymarketresearch.com/transcriptomics-technologies-market.html
Freeze Drying Equipment Market: http://www.transparencymarketresearch.com/freeze-drying-equipment-market.html
Metal Cans Market: http://www.transparencymarketresearch.com/metal-cans-market.html
The global atrial fibrillation market is categorized into the following segments:
Atrial Fibrillation Market, by Treatment Types:
Pharmacological Treatment
Anti-Arrhythmic Drugs
Anti-Coagulant Drugs
Non-Pharmacological Treatment
Catheter Ablation
- Radiofrequency Based
- Cryoablation Based
- HIFU (High Intensity Focused Ultrasound) Based
- Microwave Based
- Laser Based
Maze Surgery
Electric Cardioversion
Atrial Fibrillation Market, by Geography
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
About Transparency Market Research
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Visit :
https://connect.innovateuk.org/web/transparency-market-research-pvt.-ltd./blogs
http://marketssize.blog.com/
http://heavyindustrynews.wordpress.com/
http://medicaldevicesnews.wordpress.com/
http://rahul28feb86.wordpress.com/